101 – 110 of 241
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Decreased VIP and VPAC(2) receptor expression in the biological clock of the R6/2 Huntington's disease mouse
(
- Contribution to journal › Article
-
Mark
Restorative cell therapy for Parkinson's disease: A quest for the perfect cell
(
- Contribution to journal › Scientific review
-
Mark
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Adult neurogenesis in neurodegenerative diseases
2007) p.445-445(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
(
- Contribution to journal › Article
-
Mark
Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line - Studies in vitro and after intracerebral grafting in vivo
(
- Contribution to journal › Article
- 2006
-
Mark
Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
(
- Contribution to journal › Scientific review
-
Mark
Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
(
- Contribution to journal › Letter
-
Mark
Working memory training decreases hippocampal neurogenesis.
(
- Contribution to journal › Article